Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Singapore

Seto Wei Meng & Anor v Foo Chee Boon Edward & 2 Ors [2020] SGHC 260

In Seto Wei Meng & Anor v Foo Chee Boon Edward & 2 Ors, the High Court of the Republic of Singapore addressed issues of Tort — Negligence.

Case Details

  • Citation: [2020] SGHC 260
  • Title: Seto Wei Meng & Anor v Foo Chee Boon Edward & 2 Ors
  • Court: High Court of the Republic of Singapore
  • Date of Decision: 26 November 2020
  • Judge: Choo Han Teck J
  • Case Number: Suit No 553 of 2016
  • Tribunal/Court: High Court
  • Coram: Choo Han Teck J
  • Plaintiffs/Applicants: Seto Wei Meng & Anor (suing as administrator of the estate and on behalf of the dependants of Yeong Soek Mun, deceased)
  • Defendants/Respondents: Foo Chee Boon Edward & 2 Ors
  • Third Party: Singapore General Hospital Pte Ltd
  • Legal Area: Tort — Negligence
  • Procedural Posture: Judgment reserved; trial proceeded on plaintiffs’ negligence allegations against Dr Foo
  • Key Parties (as per metadata/extract): Seto Mun Chap (co-administrator) — Foo Chee Boon Edward — International Medical Group Holdings Pte Ltd — TCS Medical Pte Ltd — Singapore General Hospital Pte Ltd
  • Counsel for Plaintiffs: Kuah Boon Theng SC, Yong Shuk Lin Vanessa and Chain Xiao Jing Felicia (Legal Clinic LLC)
  • Counsel for First Defendant: Narayanan Sreenivasan SC, Sundararaj Palaniaapan, Lim Min (K&L Gates Straits Law LLC) (instructed) and Gan Guo Wei (Charles Lin LLC)
  • Counsel for Third Party: Mak Wei Munn, Teh Shi Ying and Ong Hui Fen Rachel (Allen & Gledhill LLP)
  • Statutes Referenced: Civil Law Act
  • Cases Cited: [2020] SGHC 260 (as provided in metadata)
  • Judgment Length: 12 pages, 7,593 words

Summary

Seto Wei Meng & Anor v Foo Chee Boon Edward & 2 Ors [2020] SGHC 260 is a High Court negligence case arising from the death of a patient following a cosmetic liposuction and fat transfer procedure. The plaintiff administrators of the deceased’s estate alleged that the surgeon, Dr Foo Chee Boon Edward, was negligent in three main respects: (1) failing to obtain informed consent by not personally advising the patient on material risks and complications; (2) performing the procedure negligently; and (3) failing to manage the patient’s postoperative deterioration appropriately, including allegedly not calling for an ambulance in time.

The court’s analysis focused heavily on the informed consent component and the causal link between any breach and the patient’s death. While the judgment extract indicates that the court found Dr Foo’s consent process inadequate in the circumstances, the court ultimately held that the plaintiffs did not establish that the lack of adequate disclosure caused the death in the relevant legal sense. The court’s reasoning illustrates the evidential burden plaintiffs face in medical negligence claims, particularly on causation where the risk is rare and the patient’s likely decision-making must be assessed on the evidence.

What Were the Facts of This Case?

The deceased, Yeong Soek Mun (“Mandy Yeong”), was a 44-year-old woman who underwent a liposuction and fat transfer surgical procedure on 28 June 2013 at TCS at Central Clinic (also known as TCS Aesthetics Central Clinic, “the Clinic”). The procedure was performed by the first defendant, Dr Foo Chee Boon Edward. The surgery began at 12.00pm and ended at about 2.00pm.

Shortly after the procedure, at 2.05pm, Mandy Yeong’s blood oxygen level dropped to 72%, according to the Clinic’s anaesthetic record. The medical evidence (as described in the extract) was that if oxygen saturation fell below 95%, action would be required to raise it above 95%. Dr Foo attempted to address the low oxygen level but was unsuccessful. By 2.45pm, Mandy Yeong suffered a cardiovascular collapse, and an ambulance was called at 2.53pm. An ambulance team arrived at the Clinic within about seven and a half minutes.

Mandy Yeong was then taken to Singapore General Hospital (“SGH”). She arrived at SGH’s Accident and Emergency (“A&E”) Ward at 3.23pm. Resuscitation efforts continued but were unsuccessful, and she died at 5.46pm on the same day. The parties accepted that the cause of death was pulmonary fat embolism, a condition in which fat globules become trapped in pulmonary blood vessels and obstruct pulmonary circulation.

The plaintiffs, who were the administrators of Mandy Yeong’s estate, brought an action against Dr Foo and the second and third defendants (who managed and owned the Clinic). The extract indicates that the second and third defendants later went into liquidation and the plaintiffs discontinued the action against them. Dr Foo initially brought SGH into the proceedings as a third party, alleging that SGH doctors were responsible for or contributed to Mandy Yeong’s death, but Dr Foo discontinued that third-party claim midway through the trial.

The case raised several negligence issues, but the extract shows the court treated informed consent as a central threshold question. The plaintiffs alleged that Dr Foo was negligent because he did not obtain informed consent: he did not personally advise Mandy Yeong on the risks and complications associated with the procedure, and he did not explain that a liposuction involving a fat transfer carried a higher risk of fat embolism, particularly in the context of a repeat procedure. Dr Foo denied these allegations and maintained that he had discussed the risks with Mandy Yeong during the 28 May 2013 consultation.

A second issue was whether Dr Foo was negligent in performing the liposuction and fat transfer procedure itself. Although the extract provided here truncates the remainder of the judgment, the pleaded case clearly included this allegation, and the court would have had to evaluate the standard of care applicable to the surgeon’s conduct and whether any breach caused the fatal outcome.

A third issue concerned postoperative management. The plaintiffs alleged that Dr Foo was negligent in attempting to manage Mandy Yeong’s postoperative condition, including failing to call for an ambulance in time. This required the court to consider what a reasonably competent clinician would have done in the circumstances and whether any delay or mismanagement contributed to the patient’s death.

How Did the Court Analyse the Issues?

The court began its liability analysis by addressing informed consent. It drew a doctrinal distinction between two different wrongs in medical law: trespass to the person where a patient does not consent to the procedure at all, and negligence where consent is given but without adequate advice. In the negligence context, the patient must prove not only that material information was omitted, but also that the omission was causative—specifically, that had the patient been properly informed, she would not have consented to the procedure. The court noted that the difference between trespass and negligence primarily affects damages, but the causation question remained decisive.

On the facts, Dr Foo claimed that he discussed the procedure and its risks, including fat embolism, with Mandy Yeong on 28 May 2013. However, his consultation notes allegedly contained no reference to such advice. The documentary evidence relied upon by Dr Foo included standard consent forms signed by Mandy Yeong on 28 June 2013. The extract indicates that the consent forms were allegedly handed to Mandy Yeong by Clinic staff, and that there was no signature by Dr Foo where his signature should have appeared. The court treated these evidential gaps as significant, particularly because Dr Foo’s claim of personal disclosure lacked documentary support.

The consent forms themselves contained passages describing “serious complications” associated with fat transfer procedures, including fat embolism, stroke, meningitis, serious infection, blindness or loss of vision, and death. The forms also included a section on “pulmonary complications”, explaining that pulmonary emboli can be life threatening or fatal in some circumstances, and that fat embolism syndrome is a very rare and possibly fatal complication of fat transfer. The court held that these passages would have sufficiently discharged the surgeon’s duty to obtain informed consent if Mandy Yeong’s attention had been drawn to them.

However, the court then turned to whether the patient was in fact placed in a position to understand the material risks. The court considered competing accounts: Dr Foo said he gave the forms on 28 May 2013 and Mandy Yeong kept them for a month before returning them signed on the day of the procedure. The plaintiffs contended that the forms were only provided on the day of the procedure. The extract notes that aside from Dr Foo, no witness provided a first-hand account, and the witness signature on the forms did not have a name matching the witness. While the evidence was “not all that clear”, the judge inclined to accept that the forms were not given in circumstances in which Mandy Yeong was likely to have read and understood them in detail.

In the judge’s view, it was unlikely that Mandy Yeong would only have signed the forms on 28 June 2013 if she had managed to read them beforehand. The absence of notes by Dr Foo fortifies the court’s belief that the danger of fat embolism was not adequately brought to Mandy Yeong’s attention before the procedure. The court also found no indication that Mandy Yeong had been apprised of such risks at any time prior to 28 June 2013, including during the 28 May 2013 consultation or before undergoing the earlier 2010 and 2011 procedures.

Despite this finding on adequacy of disclosure, the court’s analysis did not end there. The court addressed causation in the informed consent context. Even if the surgeon failed to adequately draw attention to the risk of fat embolism and the increased risk associated with a repeat liposuction with fat transfer, the plaintiffs still had to prove that the lack of adequate advice caused the patient’s death in the relevant legal sense. The judge observed that because fat embolism risk was rare, and because Mandy Yeong had personal experience with liposuction and a strong desire to correct the unevenness of her thighs, she would likely have accepted the risk and proceeded with the procedure even if properly informed. Accordingly, the court held that Dr Foo could not be said to have caused her death on this basis, because there was no direct evidence that she would not have consented otherwise; the inference from the evidence indicated she would probably have proceeded.

Although the extract truncates the remainder of the judgment, the structure of the reasoning suggests that the court would have proceeded to analyse the other pleaded negligence allegations—performance of the procedure and postoperative management—using similar legal frameworks: identifying the applicable standard of care, determining whether there was a breach, and then assessing causation and whether the breach materially contributed to the fatal pulmonary fat embolism.

What Was the Outcome?

Based on the extract provided, the court found that Dr Foo’s informed consent process was not sufficient to discharge the duty to obtain informed consent, given the lack of adequate disclosure and the evidential shortcomings in Dr Foo’s account. However, the court held that the plaintiffs failed to establish causation: even if the patient had been properly informed, the evidence suggested she would probably have consented to the procedure anyway, particularly given the rarity of the risk and her personal circumstances and motivations.

Consequently, the plaintiffs’ negligence claim against Dr Foo did not succeed on the informed consent theory. The practical effect of the decision is that the estate’s claim for damages arising from Mandy Yeong’s death could not be sustained against the surgeon on the basis of inadequate disclosure, and the court’s ultimate orders would have reflected dismissal (or at least failure to find liability) against Dr Foo, subject to the court’s further findings on the remaining allegations of negligent performance and postoperative management in the parts of the judgment not reproduced in the extract.

Why Does This Case Matter?

This decision is significant for medical negligence litigation in Singapore because it demonstrates how courts approach the informed consent duty within the negligence framework. The judgment reinforces that inadequate disclosure can amount to a breach of duty, but plaintiffs must still prove causation in the “would the patient have consented?” sense. In other words, a finding that consent was not properly informed does not automatically translate into liability for the adverse outcome.

For practitioners, the case highlights evidential best practices in consent processes. The court’s reasoning turned on documentary and procedural details: the absence of consultation notes recording risk disclosure, the lack of Dr Foo’s signature on the consent forms, and the uncertainty about when the forms were provided to the patient. These factors affected the court’s assessment of whether the surgeon adequately drew the patient’s attention to material risks.

The case also illustrates the challenge plaintiffs face where the material risk is rare. Even where a risk is serious, courts may require persuasive evidence that the patient would have declined the procedure if properly informed. Defence counsel will often focus on the patient’s prior experience, stated objectives, and the likelihood of proceeding despite the risk. Conversely, plaintiffs may need expert evidence and factual proof tailored to the patient’s decision-making to overcome the “probability” inference.

Legislation Referenced

  • Civil Law Act

Cases Cited

  • [2020] SGHC 260

Source Documents

This article analyses [2020] SGHC 260 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.

Written by Sushant Shukla

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.